Novozymes plan to further increase prices across the portfolio in response to the significant and persistent hike in incoming cost

Novozymes has experienced unprecedented cost-inflation on raw materials, energy, and logistics. To recover these headwinds, substantial price increases will be implemented.

OPENHAGEN, Denmark – 15 July 2022. Novozymes has been able to partially shield its customers from a large part of the global challenges, securing business continuity and high price stability relative to other suppliers.

However, Novozymes will further substantially increase prices at a level at least in line with the current and continued inflationary pressure no later than early 2023, to ensure continued innovation and supply robustness.

Novozymes is committed to create a sustainable future together with our customers and partners with high performing solutions in a cost-effective manner.

All customers have been or will be contacted shortly by their respective account managers.

Get in touch

Media relations

Lina Danstrup

Lina Danstrup

Head of External 30 77 05 52